Immunosuppressants 1 Flashcards
(54 cards)
what happens to the cell after CD4 T cell proliferates?
- may become cytotoxic (IC-2)
or
- produce antibodies via B cell/antigen specific B cells (IC-4, IC-5)
what are 2 major side effects/risks of ALL immunosuppressants?
- increased infection (ALL)
2. increased malignancies/cancer (MANY)
antithymocyte globulin
-class, mech?
inhibit T cell (non-specific antibody)
blocks all T cell function,
cytotoxic to/ decreases circulating lymphocytes
antithymocyte globulin
-Tx/ SE?
-acute renal transplant rejection
SE: may cause allergic response (due to polyclonal antibodies)
increased risk of infection and malignancy
abatacept
-class, mech?
receptor inhibitor
-CD80, CD86
inhibits initial step for binding site of MP and T cell activation affected
abatacept
-Tx, SE?
- RA arthritis
SE: increased risk of infection
belatacept
-class, mech?
receptor inhibitor
(CD80, CD86)
affect T cell activation
belatacept
-Tx, SE?
-renal transplant
SE: increased risk of infection, assc. with increased malignencies
what ends in ‘-mab’
monoclonal antibodies
what do monoclonal antibodies end in?
‘-mab’
administration route of monoclonal antibodies?
parenterally/ injection
administration route of ‘-mab’ drugs?
parenterally/ IV
do monoclonal bodies have more or less specific targets? more or less SE?
more specific targets
therefore,
less SE
monoclonal antibodies (‘mab’)- what does the middle of its name tell you?
target
what is ‘-li-‘?
immune cell (target)
what is ‘tu’?
tumor (target)
what are the three monoclonal antibody (‘-mab’) source prefixes?
xi
zu
u
what source is ‘-xi-‘?
chimeric source
-mouse antibody w/ some human pieces
what source is ‘-zu-‘?
humanized
-human ab w/ some mouse pieces
what source is ‘-u-‘?
fully human
most antigenic source?
least antigenic source?
most= chimeric source (xi) least= fully human (u)
natalizumab
-class, mech?
receptor blocker
-integrin
binds to alpha integrins on CD4 T cell and other immune cells (affects T cell activation)
natalizumab
-administration of route, target, source?
- parenterally/ IV
target: attack immune system (li); monoclonal antibody (mab)
source: humanized (zu)
natalizumab
-Tx, SE?
- Crohn’s + MS
SE: linked w/ progressive multifocal leukoencephalopathe (PML)
increased risk of infection